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ABSTRACT
Objective: This study was to determine the significance of meconium in the amniotic fluid of preg-
nancies complicated by preterm premature rupture ofmembranes (PPROM) without labor.
Methods:A case-control study of 31 pregnancies complicated by PPROM at 27-36 weeks gesta-
tion with meconium present (study group) and 93 pregnancies complicated byPPROM but without
meconium was performed. The patients were matched for year ofdelivery, gestational age, race, and
parity. Pregnancy and neonatal outcome variables of the 2 groups were compared.
Results: The incidence of early onset neonatal sepsis was significantly increased in the study
group (16.1% vs. 1.1%; P < 0.001). Similarly, chorioamnionitis (48.3% vs. 22.5%; P < 0.01), cesar-
ean delivery for a nonreassuring fetal heart rate pattern (19.4% vs. 3.2%; P < 0.01), a 5-min Apgar
score < 7 (22.5% vs. 8.6%;P < 0.05), and fetal growth retardation (FGR) (12.9% vs. 2.2%;P < 0.05)
were also more common in pregnancies complicated byPPROM with meconium. The mean umbil-
ical cord arterial pH was significantly lower in these pregnancies (7.18 _+ 0.07 vs. 7.28 0.08;
P < 0.001). After controlling for confounding variables with multiple logistic regression analysis, we
found that meconium in the amniotic fluid remained associated with early onset neonatal sepsis.
Conclusions: The presence of meconium in the amniotic fluid of pregnancies complicated by
PPROM is associated with an increased incidence of early onset neonatal group B 13-hemolytic
streptococcus (GBBS) sepsis. (C) 1995 Wiley-Liss, Inc.
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reterm premature rupture of membranes
(PPROM) is directly related to 30-40% of the
cases of preterm delivery. The etiology of
PPROM is most likely multifactorial, but appears
to be strongly related to infection,
2 specifically with
group B [3-hemolytic streptococcus (GBBS).
3-s In-
frequently, PPROM is associated with the appear-
ance of meconium, as the presence of meconium in
the amniotic fluid is considered a part of the matu-
ration process of the gastrointestinal tract.
6 Conse-
quently, the significance of meconium in preterm
pregnancies with or withoutPPROM is unknown.
Several reports suggest an association between meco-
nium and microbial invasion of the amniotic cavity
in preterm pregnancies and between the presence of
meconium and neonatal infection.
7-1 To address
the significance of this relationship, we investigated
the outcomes of pregnancies complicated by
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PPROM with and without meconium in the amni-
otic fluid.
SUBJECTS AND METHODS
The perinatal data base of Northwestern Memorial
Hospital from 1986 to 1992 was reviewed to iden-
tify patients with PPROM associated with meco-
nium-stained amniotic fluid but without regular
uterine contractions at the time of admission. The
presence or absence of meconium-stained amniotic
fluid was recorded from the physician’s admitting
note. Forty-two patients were identified, and the
maternal and neonatal charts were reviewed by the
authors (M.J.K., E.W.). The gestational age was
determined by reliable menstrual dates or first- or
second-trimester ultrasound examination and was
confirmed by Ballard examination of the neonate.
Eleven pregnancies were excluded from the study
because of discrepancies in gestational age assign-
ment which suggested the pregnancy might be
>3 6 weeks gestation. Thirty-one pregnancies with
PPROM associated with meconium-stained amni-
otic fluid remained and were analyzed; 3 of these
pregnancies were twin gestations and only twin A
was included in the study. The control group con-
sisted of 93 nonlaboring singleton pregnancies com-
plicated by PPROM without meconium. Using a
3:1 matching scheme, we selected the charts in the
perinatal data base of consecutive pregnancies for
thePPROM associated with meconium-stained am-
niotic fluid group and matched these patients for
year of delivery, gestational age at delivery, parity,
find race.
During the study period, all pregnancies com-
plicated by PPROM with or without meconium
were managed expectantly, awaiting spontaneous
labor. Cervicovaginal cultures for GBBS were ob-
tained upon admission. Signs of maternal infection
or fetal compromise prompted an induction of la-
bor. Treatment prior to labor for a positive GBBS
cervicovaginal culture was left to the discretion of
the attending physician. The patients with positive
cultures received ampicillin or erythromycin intra-
partum. Beginning in 1989, the patients with un-
known culture status also received intrapartum pro-
phylactic antibiotics.
Demographic and outcome variables were ab-
stracted from the maternal and neonatal medical
records. The latency period was calculated as the
time from documented rupture of membranes to
the time of delivery. Oligohydramnios was noted if
the largest vertical pocket of amniotic fluid was <2
cm or if the total amniotic fluid index was <5 cm.
Chorioamnionitis was defined as a maternal tem-
perature >38C with uterine tenderness and sus-
tained fetal tachycardia. The route of delivery and
indication for cesarean delivery were recorded from
the patient’s chart. Endometritis was defined as a
fever of >38C with uterine tenderness in any 2
of the first 10 days postpartum, exclusive of the
first 24 h.
The diagnosis of early onset neonatal sepsis was
made if there were clinical symptoms of sepsis in
association with positive blood or cerebrospinal-
fluid cultures within 72 h of birth. Fetal growth
retardation (FGR) was defined as a birth weight
less than the tenth percentile for gestational age, as
determined by Brenner et al.
11 Respiratory distress
syndrome (RDS) was diagnosed based upon the
observation of chest retractions, grunting, cyano-
sis, a need for supplemental oxygen therapy, and a
reticular pattern or air bronchograms on chest ra-
diograph. Neonatal intraventricular hemorrhage
(IVH) was defined as hemorrhage in the
subependymal germinal matrix rupturing into the
lateral ventricle and was diagnosed by ultrasound
or computerized tomography. Only grade III and
IV IVH were recorded.
2 Necrotizing enterocolitis
was diagnosed based on clinical signs of abdominal
distention, bloody stool, and radiographic signs of
intestinal distention or pneumatosis intestinalis.
The data were analyzed using SPSS/PC+, ver-
sion 5.0 (Chicago, IL). The continuous variables
were analyzed by Student’s t-test. Dichotomous
variables were analyzed by McNemar chi-squared
test and Fisher exact test. A conditional multiple
logistic regression analysis was used to evaluate the
effects of several potential confounding variables.
The statistical significance was assumed at
P < 0.05. A 3:1 matching scheme was used to
increase the power of the study to detect a clinically
significant difference between cases and controls.
RESULTS
There was no difference between the study and
control groups in the mean maternal age
(27.2 ---
5.8 vs. 29.5 -+- 6.1 years), mean gesta-
tionalageat admission (33.2 + 2.7 vs. 32.8 2.4
weeks), parity (32.3% vs. 30.1% nulliparous), and
race. However, the number of nonprivate patients
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TABLE I. Antepartum, intrapartum, and postpartum course
a
Cases Controls
(N 31) (N 93)
Latency (h) 42.6 _+ 60 II 5.9 139
Oligohydramnios 15 (48.3%) 44 (47.3%)
Maternal GBBS 12/26 (46.1%) 15/72 (20.8%)
Vaginal exams 3.5 -+ 1.5 3.9 1.3
Duration of internal monitoring (h) 3.64 3.7 4.66 -+ 4.45
Chorioamnionitis 15 (48.3%) 21 (22.5%)
Antibiotics during labor 20 (64.5%) 53 (56.9%)
Chorioamnionitis treated with 13 (86.7%) 20 (95.2%)
antibiotics during labor
Cesarean delivery 9 (29.0%) 13 (14.0%)
Cesarean delivery for nonreassuring 6 (19.4%) 3 (3.2%)
fetal heart rate pattern
Postpartum endometritis 8 (25.8%) 17 (18.2%)
<0.001
NS
<0.0S
NS
NS
<0.01
NS
NS
NS
<0.01
NS
aMean +- SD. NS, not significant.
TABLE 2. Neonatal outcome
Cases Controls
(N 31) (N 93)
Birth weight (g) 2,222 +- 522 2,256 +- 563
5-min Apgar <7 7 (22.5%) 8 (8.6%)
ART pH 7.18 _+ 0.07 7.28 -+ 0.08
SCN (days) 11.6 +_ 14.7 5.6 -+ 8.9
Neonatal sepsis 5 16. 1%) (I. I%)
FGR 4 (I 2.9%) 2 (2.2%)
RDS 7 (22.5%) 20 (21.5%)
IVH grade Ill-IV (3.2%) 3 (3.2%)
NEC (3.2%) (I.1%)
Neonatal death 2 (6.4%) 2 (2.2%)
NS
<0.05
<0.001
<O.OS
<0.001
<0.05
NS
NS
NS
NS
aMean _+ SD. ART pH, umbilical cord arterial pH; SCN, special-care nursery; NEC, necrotizing enterocolitis.
was significantly higher in the study group (71.0%
vs. 48.4%; P < 0.05). The results of the pregnan-
cies and labor courses are shown in Table 1. The
latency period was significantly shorter in the
PPROM associated with meconium-stained amni-
otic fluid group. The results of the cervicovaginal
cultures for GBBS were retrievable for 26 patients
(83.9%) in the PPROM associated with meco-
nium-stained amniotic fluid group and 72 patients
(77.4%) in the PPROM group. Maternal GBBS
colonization, chorioamnionitis, and cesarean deliv-
ery for a nonreassuring fetal heart rate pattern were
significantly more common in the PPROM associ-
ated with meconium-stained amniotic fluid group.
Table 2 summarizes the neonatal outcome vari-
ables. Early onset neonatal sepsis was significantly
more common in the PPROM associated with
meconium-stained amniotic fluid group. GBBS was
the organism responsible for all 5 cases of neonatal
sepsis in the study group and for the case of
neonatal sepsis in the control group. No other patho-
genic organisms including Listeria monocytogenes
were incubated from the neonates or maternal cer-
vix. In 3 of the cases of neonatal sepsis in the
PPROM associated with meconium-stained amni-
otic fluid group, at least intrapartum dosage of
antibiotics was administered >2 h before delivery
for clinical signs of chorioamnionitis. In the other
2 cases of neonatal sepsis, the interval from the
administration of antibiotics to delivery was < h
because of the rapid course of labor. No intrapar-
tum antibiotics were administered in the case of
neonatal sepsis in the PPROM group. The mean
umbilical cord arterial pH was significantly lower
in the PPROM associated with meconium-stained
amniotic fluid group, and a 5-rain Apgar score <7
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TABLE 3. Neonatal outcomes by gestational age groups
a
<28 weeks <32 weeks 32-36 weeks
Cases Controls Cases Controls
(N 3) (N 9) P (N 8) (N 24)
Cases
(N 23)
Controls
(N 69)
Birth weight (g) 1,206 _+ 305 1,220 _+ 423 NS 1,685 -+ 480 1,687 _+ 665 NS
5-min Apgar <7 (33.3%) 3 (33.3%) NS 5 (62.5%) 4 (16.7%) <0.05
ART pH 7.16 -+ 0.06 7.22 _+ 0.05 NS 7.16 0.08 7.26 _+ 0.07 <0.01
SCN (days) 47.4 -
22.1 22.7 10.6 <0.05 25.8 +- 21.4 13.2 +- 9.9 <0.05
Neonatal sepsis (33.3%) 0 NS 3 (37.5%) (4.2%) <0.05
FGR 1(33.3%) 0 NS 3 (37.5%) 1(4.2%) <0.05
RDS 3 (100%) 8 (88.9%) NS 5 (62.5%) 17 (70.8%) NS
IVH grade Ill-IV (33.3%) 2 (22.2%) NS (12.5%) 2 (8.3%) NS
NEC 0 (I 1.1%) NS (12.5%) (4.2%) NS
Neonatal death (33.3%) (I 1.1%) NS 2 (25%) 2 (8.3%) NS
2,358 +-- 497
2 (8.7%)
7.19 _+ 0.06
7.4 +_ 8.0
2 (8.7%)
1(4.3%)
2 (8.7%)
0
0
0
2,471 374
4 (5.8%)
7.3 -+ 0.07
2.9 5.6
o
(.5%)
3 (4.34%)
(.s%)
0
0
NS
NS
<0.001
<0.0S
0.06
NS
NS
NS
NS
NS
aMeans +- SD. ART pH, umbilical cord arterial pH; SCN, special-care nursery; NEC, necrotizing enterocolitis.
was more common. The incidence ofFGR and the
mean length of stay in the special-care nursery were
also significantly greater in the PPROM associated
with meconium-stained amniotic fluid group, al-
though the neonatal mortality was similar in the 2
groups.
The apparent association between PPROM as-
sociated with meconium-stained amniotic fluid and
early onset neonatal sepsis was further investigated
by multiple logistic regression analysis. After we
controlled for maternal GBBS colonization, latency
period, chorioamnionitis, use of prophylactic anti-
biotics, socioeconomic status (private vs. service
patient), and FGR, meconium in the amniotic fluid
remained associated with neonatal GBBS sepsis
(odds ratio 11.3, 95% confidence interval [CI]:
1.2-105.0). Chorioamnionitis was the only other
variable that remained associated with neonatal sep-
sis (odds ratio 29.1, 95% CI: 1.6-73).
The 6 GBBS-positive patients whose neonates
had early onset neonatal sepsis had a higher inci-
dence of chorioamnionitis compared with the other
21 GBBS-positive patients (83.3% vs. 33.3%;
P < 0.05); however, the number of nonprivate
patients (100% vs. 80.1%), administration of anti-
biotics during labor (83.3% vs. 71.4%), and num-
ber ofFGR neonates (33.3% vs. 4.8%) were com-
parable in these subgroups.
Table 3 summarizes the neonatal outcome vari-
ables by gestational age groups. Early onset neona-
tal sepsis was significantly more common in pa-
tients with PPROM associated with meconium-
stained amniotic fluid who were <32 weeks
gestation and approached significance in those be-
tween 32 and 36 weeks gestation. The mean umbil-
ical cord arterial pI-I was significantly lower in the
PPROM associated with meconium-stained amni-
otic fluid group <32 weeks gestation and between
32 and 3 6 weeks gestation.
DISCUSSION
Our results demonstrate that PPROM associated
with meconium-stained amniotic fluid is associated
with early onset neonatal sepsis secondary to GBBS.
Early onset neonatal sepsis in the PPROM associ-
ated with meconium-stained amniotic fluid group
(16.1%) was increased appreciably over that in the
control group (1.1%) and was higher than in prior
studies reporting neonatal infectious morbidity fol-
lowing PPROM and prematurity.
13-z2 Addition-
ally, the latency period from PPROM to delivery
was shorter, labor was more likely to be compli-
cated by chorioamnionitis, and cesarean delivery
for a nonreassuring fetal heart rate pattern was
more common in the PPROM associated with
meconium-stained amniotic fluid group. Because
of the 7-year span of this study, there was not a
uniform approach to cervicovaginal cultures or the
administration of intrapartum antibiotics. How-
ever, after controlling for potential confounding
variables, we found that meconium in the amniotic
fluid at the time of ruptured membranes remained
a marker for early onset neonatal sepsis.
Previous reports have suggested an association
between the presence of meconium and infectious
neonatal morbidity in the preterm infant. In one
report, neonatal sepsis was found to be increased in
premature in(ants who were born to febrile moth-
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ers with the presence of meconium in the amniotic
fluid.
23 The organism most often associated with
sepsis was Escherichia coli. In another report link-
ing meconium-stained amniotic fluid to perinatal
infection, the infectious outcomes were mostly en-
teritis, primarily caused by Streptococcus (group not
specified).
9 Meconium staining of the amniotic
fluid has also been reported to be associated with
intraamniotic infection in patients with preterm la-
bor who had amniocenteses performed for amniotic
fluid cultures.
7 A marked association also has been
found between the presence ofL. monocytogenes and
meconium-stained amniotic fluidS; however, in our
study, L. monocytogenes was not isolated from ma-
ternal or neonatal cultures. To the best of our
knowledge, ours is the first study specifically link-
ing the presence of meconium in amniotic fluid to
GBBS neonatal sepsis.
The mechanism through which intrauterine fe-
tal infection may be associated with meconium pas-
sage is not well defined. The presence ofmeconium
may predispose to bacterial overgrowth. In vitro
studies have found that meconium enhances bacte-
rial growth in amniotic fluid and impairs the natu-
ral antibacterial properties of the amniotic
fluid. 10,24 In a study focused on GBBS, meconium
specifically promoted the growth ofGBBS in amni-
otic fluid, zs Alternatively, an established infection
may precipitate the passage of meconium. The pre-
term fetus, as opposed to the term fetus, is at risk
for acquiring infections from even a relatively low
colony count
26 and the presence of meconium may
increase this risk. It should be noted, however,
based upon mid-trimester amniocentesis data, that
the presence of green-stained amniotic fluid may be
the result of contamination of the amniotic fluid
with hemoglobin and its catabolic products.
27
Our findings suggest that pregnancies compli-
cated by PPROM associated with meconium-
stained amniotic fluid prior to the onset of labor are
at increased risk for neonatal infectious morbidity.
This association was particularly seen in pregnan-
cies <32 weeks gestation and approached signifi-
cance in those between 32 and 36 weeks gestation.
In addition, these pregnancies are more likely to be
complicated by chorioamnionitis, abnormal fetal
heart rate patterns, lower Apgar scores and umbili-
cal cord arterial pH, and FGR.
After controlling for potentially confounding
variables, we found that meconium remained a
marker for early onset neonatal sepsis, with an odds
ratio of 11.3. Consequenty, pregnancies compli-
cated by PPROM associated with meconium-
stained amniotic fluid should be considered at high
risk for neonatal sepsis and may benefit from early
administration of antibiotics begun on admission
and continued through delivery. In the case of
proven pulmonary maturity induction of labor may
be indicated to reduce fetal exposure to infection in
utero. Prospective studies will be needed to address
these issues.
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